Thimerosal Content in Some US Licensed Vaccines
Vaccine |
Brand Name |
Presentation |
Manufacturer |
Thimerosal |
Mercury |
Influenza: 2018/19 Formula | Afluria | Multi-dose vial | Seqirus | 0.01% | 24.5 mcg |
Afluria Quad | Multi-dose vial | Seqirus | 0.01% | 24.5 mcg | |
Flucelvax Quad | Multi-dose vial | Seqirus | 0.01% | 25 mcg | |
Flulaval Quad | Multi-dose vial | ID Biomedical | 0.01% | <25 mcg | |
Fluvirin | Prefilled syringe | Seqirus | * | ≤1 mcg * | |
Fluvirin | Multi-dose vial | Seqirus | 0.01% | 25 mcg | |
Fluzone Quad | Multi-dose vial | sanofi pasteur | 0.01% | 25 mcg | |
Japanese Encephalitis | JE-Vax | Single dose vial | sanofi pasteur | 0.007% | |
Meningococcal | Menomune-ACYW135 | Diluent for Multi-dose | sanofi pasteur | 0.01% | 24.5 |
Tetanus and Diphtheria Toxoids adsorbed | TDVAX | Single dose vial | MassBiologics | * | ≤0.3 mcg * |
* This product should be considered equivalent to thimerosal-free products. This vaccine may contain trace amounts (<0.3 mcg) of mercury left after postproduction thimerosal removal; these amounts have no biological effect. JAMA 1999;282(18) and JAMA 2000;283(16). |
The information on this page was last updated on June 11 2019 | © 2019 Institute for Vaccine Safety